At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Aug 10, 2026 at 16:28 ET
Four Merck executives sold a combined ~$12M in open-market shares over two days following the Q2 2026 earnings release. The total is ~0.004% of Merck's $317.6B market cap, immaterial. Most sales coincide with option exercises and are likely routine post-vesting liquidity events, not a bearish signal.
- 4 insiders sold open-market shares: EVP Guindo Chirfi ($1.97M), EVP David Michael Williams ($6.81M), EVP David R. Maraldo ($2.41M), EVP Richard R. DeLuca ($0.79M)
- Total open-market sales: ~$11.97M
- Sales occurred on Aug 5-6, 2026, within 6 days of Merck's Q2 2026 earnings release (Aug 4)
- Multiple sales were accompanied by derivative exercises (non-cash), indicating routine option monetization
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access